TOPIGEN Pharmaceuticals Inc., a biopharmaceutical company specializing in innovative respiratory therapeutics, today announced that Dr. Paul Wotton, President and Chief Executive Officer, will be presenting at the 8th Annual BIO CEO & Investor Conference in New York City (February 14-15, 2006), at the Waldorf Astoria Hotel. Dr. Wotton is presenting on Wednesday, February 15th, at 11:30 AM in the Park Avenue Suite Center/North and will be available for one-on-one meetings during the conference.
